KALEIDO BIOSCIENCES INC's ticker is KLDO and the CUSIP is 483347100. A total of 71 filers reported holding KALEIDO BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $31,000 | -96.2% | 500,500 | 0.0% | 0.00% | -94.3% |
| Q1 2022 | $826,000 | -30.9% | 500,500 | 0.0% | 0.04% | +9.4% |
| Q4 2021 | $1,196,000 | -56.2% | 500,500 | 0.0% | 0.03% | -47.5% |
| Q3 2021 | $2,733,000 | -26.6% | 500,500 | 0.0% | 0.06% | -19.7% |
| Q2 2021 | $3,724,000 | -8.1% | 500,500 | 0.0% | 0.08% | +5.6% |
| Q1 2021 | $4,054,000 | -11.0% | 500,500 | 0.0% | 0.07% | -26.5% |
| Q4 2020 | $4,555,000 | -17.8% | 500,500 | 0.0% | 0.10% | -27.4% |
| Q3 2020 | $5,541,000 | +49.0% | 500,500 | 0.0% | 0.14% | +29.8% |
| Q2 2020 | $3,719,000 | +20.8% | 500,500 | 0.0% | 0.10% | -20.0% |
| Q1 2020 | $3,078,000 | +22.5% | 500,500 | 0.0% | 0.13% | +34.0% |
| Q4 2019 | $2,513,000 | -62.9% | 500,500 | -44.4% | 0.10% | -64.3% |
| Q3 2019 | $6,781,000 | -35.1% | 900,500 | 0.0% | 0.27% | -35.5% |
| Q2 2019 | $10,446,000 | -24.0% | 900,500 | -5.0% | 0.42% | -24.8% |
| Q1 2019 | $13,737,000 | – | 947,419 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 17,360,710 | $106,768,000 | 5.00% |
| HARBOURVEST PARTNERS LLC | 1,167,166 | $7,178,000 | 3.46% |
| Palo Alto Investors LP | 787,999 | $4,846,000 | 0.41% |
| Artal Group S.A. | 500,500 | $3,078,000 | 0.13% |
| BAINCO INTERNATIONAL INVESTORS | 22,037 | $136,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $656,000 | 0.02% |
| Baillie Gifford | 440,000 | $2,706,000 | 0.00% |
| FMR LLC | 2,276,007 | $13,997,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 250,372 | $1,540,000 | 0.00% |